In patients with glioblastoma and lymphopenia after standard therapy, neither the total lymphocyte count nor CD4+ cell recovery was augmented by the reinfusion of autologous lymphocytes harvested using apheresis prior to therapy (40). The gene discussed is CD4; the disease is lymphopenia.